$4.60
Today
as of Aug 5, 16:53 ET
Last 30 days
Recent Press Releases & News
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Overview
52-week range
$2.77
$5.21
75% of range
Avg surprise (last 3)
-3.0%
Avg reaction (last 2)
-0.2%
50% positive
Latest IV / EM
72%
EM ±12.0% · $5 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.35 | $-0.47 | +25.5% | +50.0% | -7.5% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.78 | $-0.53 | -47.2% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.70 | $-0.80 | +12.5% | — | +7.0% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | BMO | -$0.34 | -$0.78 | +56.4% |